UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Making Progress in PTCL: Significant Unmet Needs

Oncology (Williston Park, N.Y.), 2022-05, Vol.36 (5), p.296-296

Nasta, Sunita D

2022

Volltextzugriff (PDF)

Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease

Clinical lymphoma, myeloma and leukemia, 2024-09

2024

Volltextzugriff (PDF)

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

Oncotarget, 2022-11, Vol.13 (1), p.1237-1244

2022

Volltextzugriff (PDF)

Genomic features of newly diagnosed large B cell lymphoma with or without subsequent disease progression

Cancer research communications, 2024-10

2024

Volltextzugriff (PDF)

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

Molecular imaging and biology, 2021-12, Vol.23 (6), p.818-826

2021

Volltextzugriff (PDF)

CAR T-Cell Immunotherapy in Minority Patients with Lymphoma

NEJM evidence, 2024-04, Vol.3 (4), p.EVIDoa2300213

2024

Volltextzugriff (PDF)

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma

European Medical Journal (Chelmsford, England), 2018-12, Vol.3 (4), p.40-48

2018

Volltextzugriff (PDF)

Chimeric antigen receptor modified T cells directed against CD19 (CTL019) induce clinical responses in patients with relapsed or refractory CD19+ lymphomas

Cytotherapy (Oxford, England), 2015-06, Vol.17 (6), p.S13-S13

2015

Volltextzugriff (PDF)

Lenalidomide plus rituximab in patients with rituximab-resistant indolent B-cell and mantle cell lymphomas: 10-year follow-up

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.7539-7539

2021

Volltextzugriff (PDF)

TCL-664 Clinical Characteristics of Patients With Peripheral T-Cell Lymphoma (PTCL) and Concomitant Hepatitis B Virus (HBV) Infection

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S526-S526

2024

Volltextzugriff (PDF)

Clinical Characteristics of Patients With Peripheral T-Cell Lymphoma (PTCL) and Concomitant Hepatitis B Virus (HBV) Infection

Clinical lymphoma, myeloma and leukemia, 2024-09, Vol.24, p.S230-S230

2024

Volltextzugriff (PDF)

TP53 Mutations Detected By Clinical Laboratory Mutation Analysis Predict for Inferior Clinical Outcomes in Patients with Newly-Diagnosed Aggressive B Cell Lymphomas, Including Those with High-Risk Features

Blood, 2023-11, Vol.142 (Supplement 1), p.1739-1739

2023

Volltextzugriff (PDF)

CD5 Expression in Mature T Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.6195-6195

2023

Volltextzugriff (PDF)

Impact of Genetic Mutations on Survival Following Receipt of Commercial CART19 for Patients Diagnosed with Aggressive B Cell Lymphoma

Blood, 2023-11, Vol.142 (Supplement 1), p.3518-3518

2023

Volltextzugriff (PDF)

Outcomes with bendamustine lymphodepletion prior to brexucabtagene autoleucel for mantle cell lymphoma

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e19540-e19540

2023

Volltextzugriff (PDF)

Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial

Blood, 2022-11, Vol.140 (Supplement 1), p.3726-3727

2022

Volltextzugriff (PDF)

Characterizing Mature T-Cell Lymphoma Patients' Outcomes By Race

Blood, 2022-11, Vol.140 (Supplement 1), p.12013-12015

2022

Volltextzugriff (PDF)

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with Newly-Diagnosed Germinal Center Aggressive B Cell Lymphoma

Blood, 2022-11, Vol.140 (Supplement 1), p.6653-6655

2022

Volltextzugriff (PDF)

Rituximab, Cyclophosphamide, Etoposide and Prednisone for the Treatment of Post-Transplantation Lymphoproliferative Disorder

Blood, 2022-11, Vol.140 (Supplement 1), p.6715-6716

2022

Volltextzugriff (PDF)

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with First Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Curative-Intent Immunochemotherapy

Blood, 2022-11, Vol.140 (Supplement 1), p.6702-6703

2022

Volltextzugriff (PDF)

Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions

Blood, 2023-11, Vol.142 (Supplement 1), p.2341-2341

2023

Volltextzugriff (PDF)

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Palliative-Intent Therapy

Blood, 2022-11, Vol.140 (Supplement 1), p.9514-9515

2022

Volltextzugriff (PDF)

Association of PET/CT response assessment prior to CAR T-cell infusion with outcomes after CAR T-cell therapy in aggressive B-cell lymphomas

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e19568-e19568

2021

Volltextzugriff (PDF)

Willingness to travel for CAR-T: A choice-based conjoint analysis

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18503-e18503

2021

Volltextzugriff (PDF)

Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.7004-7004

2024

Volltextzugriff (PDF)

1 – 25 von 180

Suche als RSS-Feed

Aktive Filter

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(173)
Mit Volltextzugriff
(174)

Publikationsform

Artikel
(177)
Berichte
(3)

Sprache

Englisch
(180)

Erscheinungsjahr

n.n

Thema

Humans
(5)
Aged
(3)
Chemotherapy
(3)
Female
(3)
Adult
(2)
Biopsy
(2)
Dlbcl
(2)
Hematology, Oncology And Palliative Medicine
(2)
Immunotherapy
(2)
Infectious Diseases
(2)
Lymphoma
(2)
Male
(2)
Middle Aged
(2)
Non-Hodgkin Lymphoma
(2)
Non-Hodgkin's Lymphoma
(2)
Primary Cns Lymphoma
(2)
Tcl
(2)
631/326/2565/2134
(1)
692/699/67/1059/2325
(1)
692/699/67/1990/283/2125
(1)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Making Progress in PTCL: Significant Unmet Needs

Analysis of Histologic, Immunohistochemical and Genomic Features of Large B Cell Lymphoma Tumors May Predict Response to Polatuzumab Vedotin Based Therapy in Patients With Relapsed/Refractory Disease

Mutation analysis performed on tumor biopsies from patients with newly-diagnosed germinal center aggressive B cell lymphomas

Genomic features of newly diagnosed large B cell lymphoma with or without subsequent disease progression

18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Following Chimeric Antigen Receptor T-cell Therapy in Large B-cell Lymphoma

CAR T-Cell Immunotherapy in Minority Patients with Lymphoma

Newest Approaches in Immunotherapy for Non-Hodgkin’s Lymphoma

Chimeric antigen receptor modified T cells directed against CD19 (CTL019) induce clinical responses in patients with relapsed or refractory CD19+ lymphomas

Lenalidomide plus rituximab in patients with rituximab-resistant indolent B-cell and mantle cell lymphomas: 10-year follow-up

TCL-664 Clinical Characteristics of Patients With Peripheral T-Cell Lymphoma (PTCL) and Concomitant Hepatitis B Virus (HBV) Infection

Clinical Characteristics of Patients With Peripheral T-Cell Lymphoma (PTCL) and Concomitant Hepatitis B Virus (HBV) Infection

TP53 Mutations Detected By Clinical Laboratory Mutation Analysis Predict for Inferior Clinical Outcomes in Patients with Newly-Diagnosed Aggressive B Cell Lymphomas, Including Those with High-Risk Features

CD5 Expression in Mature T Cell Lymphoma

Impact of Genetic Mutations on Survival Following Receipt of Commercial CART19 for Patients Diagnosed with Aggressive B Cell Lymphoma

Outcomes with bendamustine lymphodepletion prior to brexucabtagene autoleucel for mantle cell lymphoma

Low-Dose Radiation Therapy with Nivolumab in Patients with Relapsed/Refractory Hodgkin Lymphoma: Results of the Phase II Radvax Trial

Characterizing Mature T-Cell Lymphoma Patients' Outcomes By Race

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with Newly-Diagnosed Germinal Center Aggressive B Cell Lymphoma

Rituximab, Cyclophosphamide, Etoposide and Prednisone for the Treatment of Post-Transplantation Lymphoproliferative Disorder

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with First Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Curative-Intent Immunochemotherapy

Safety of CAR-T Cell Therapy in Asymptomatic Patients with Positive Respiratory Viral Testing Prior to CAR-T Infusions

Clinical Laboratory Mutation Analysis Performed on Tumor Biopsies from Patients with Relapsed/Refractory Aggressive B Cell Lymphoma Treated with Palliative-Intent Therapy

Association of PET/CT response assessment prior to CAR T-cell infusion with outcomes after CAR T-cell therapy in aggressive B-cell lymphomas

Willingness to travel for CAR-T: A choice-based conjoint analysis

Safety and efficacy of armored huCART19-IL18 in patients with relapsed/refractory lymphomas that progressed after anti-CD19 CAR T cells

Aktive Filter

Suchergebnisse filtern